1. Home
  2. OGN vs CCOI Comparison

OGN vs CCOI Comparison

Compare OGN & CCOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CCOI
  • Stock Information
  • Founded
  • OGN 1923
  • CCOI 1999
  • Country
  • OGN United States
  • CCOI United States
  • Employees
  • OGN N/A
  • CCOI N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CCOI Telecommunications Equipment
  • Sector
  • OGN Health Care
  • CCOI Consumer Discretionary
  • Exchange
  • OGN Nasdaq
  • CCOI Nasdaq
  • Market Cap
  • OGN 4.0B
  • CCOI 3.6B
  • IPO Year
  • OGN N/A
  • CCOI N/A
  • Fundamental
  • Price
  • OGN $14.73
  • CCOI $61.65
  • Analyst Decision
  • OGN Hold
  • CCOI Buy
  • Analyst Count
  • OGN 5
  • CCOI 8
  • Target Price
  • OGN $20.80
  • CCOI $80.25
  • AVG Volume (30 Days)
  • OGN 3.8M
  • CCOI 439.2K
  • Earning Date
  • OGN 05-01-2025
  • CCOI 05-08-2025
  • Dividend Yield
  • OGN 7.61%
  • CCOI 6.42%
  • EPS Growth
  • OGN N/A
  • CCOI N/A
  • EPS
  • OGN 3.33
  • CCOI N/A
  • Revenue
  • OGN $6,403,000,000.00
  • CCOI $955,704,000.00
  • Revenue This Year
  • OGN N/A
  • CCOI $9.97
  • Revenue Next Year
  • OGN $0.71
  • CCOI $8.56
  • P/E Ratio
  • OGN $4.42
  • CCOI N/A
  • Revenue Growth
  • OGN 2.23
  • CCOI 7.29
  • 52 Week Low
  • OGN $13.87
  • CCOI $50.80
  • 52 Week High
  • OGN $23.10
  • CCOI $86.76
  • Technical
  • Relative Strength Index (RSI)
  • OGN 46.35
  • CCOI 24.86
  • Support Level
  • OGN $14.81
  • CCOI $60.06
  • Resistance Level
  • OGN $14.94
  • CCOI $69.63
  • Average True Range (ATR)
  • OGN 0.52
  • CCOI 2.02
  • MACD
  • OGN -0.08
  • CCOI -0.46
  • Stochastic Oscillator
  • OGN 42.03
  • CCOI 13.84

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CCOI Cogent Communications Holdings Inc.

Cogent carries over one fifth of the world's internet traffic over its network and is a broadband provider for businesses. Cogent's corporate customers are in high-rise office buildings; the firm provides them with two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for over half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.

Share on Social Networks: